0001022079-17-000009.txt : 20170206
0001022079-17-000009.hdr.sgml : 20170206
20170206163655
ACCESSION NUMBER: 0001022079-17-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170202
FILED AS OF DATE: 20170206
DATE AS OF CHANGE: 20170206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E
CENTRAL INDEX KEY: 0001222679
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 17576026
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
wf-form4_148641700170465.xml
FORM 4
X0306
4
2017-02-02
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222679
PREVOZNIK MICHAEL E
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
0
1
0
0
SVP & General Counsel
Common Stock
2017-02-02
4
M
0
30000
51.20
A
71918
D
Common Stock
2017-02-02
4
S
0
30000
92.395
D
41918
D
Common Stock
2017-02-02
4
M
0
15000
55.65
A
56918
D
Common Stock
2017-02-02
4
S
0
15000
92.383
D
41986
D
Common Stock
4809
I
401(k)/SDCP
Stock Options (Right to Buy)
51.2
2017-02-02
4
M
0
30000
51.20
D
2019-02-11
Common Stock
30000.0
0
D
Stock Options (Right to Buy)
55.65
2017-02-02
4
M
0
15000
55.65
D
2020-02-10
Common Stock
15000.0
15000
D
This transaction was executed in multiple trades at prices ranging from $92.08 to $92.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $92.06 to $92.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik
2017-02-06